Cetera Advisor Networks’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$99.1K Sell
11,619
-50
-0.4% -$417 ﹤0.01% 2693
2023
Q4
$98.2K Hold
11,669
﹤0.01% 2648
2023
Q3
$118K Hold
11,669
﹤0.01% 2547
2023
Q2
$150K Sell
11,669
-285
-2% -$3.54K ﹤0.01% 2405
2023
Q1
$111K Buy
11,954
+535
+5% +$6.19K ﹤0.01% 2425
2022
Q4
$122K Buy
11,419
+1,000
+10% +$5.45K ﹤0.01% 2354
2022
Q3
$42K Sell
10,419
-100
-1% -$675 ﹤0.01% 2023
2022
Q2
$77K Buy
+10,519
New +$83.2K ﹤0.01% 1977
2020
Q3
Sell
-8,000
Closed -$135K 2569
2020
Q2
$135K Buy
+8,000
New +$101K ﹤0.01% 1340

Other funds holding PROF

Cetera Advisor Networks's PROF Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Profound Medical (PROF) stake by 0.43% in Q1 2024, selling an estimated $417 and leaving 11,619 shares worth $99.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Cetera Advisor Networks first reported a position in PROF in Q2 2020 and has held it in 9 quarters since. The position peaked at $150K in Q2 2023. 43 funds tracked by Wall St. Rank hold PROF as of Q1 2024.

  • Cetera Advisor Networks held 11,619 shares of Profound Medical worth $99.1K as of Q1 2024.
  • Cetera Advisor Networks sold 50 Profound Medical shares in Q1 2024, an estimated $417.
  • Profound Medical made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2693 holding.
  • Cetera Advisor Networks first reported a position in Profound Medical in Q2 2020 and has held it in 9 quarters since.
  • Cetera Advisor Networks's Profound Medical position peaked at $150K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.